Our Work

Our Work Around The World


The map shows our completed, ongoing and future projects. Click on highlighted countries to see what we are doing around the world.

To support our work with a tax-deductible contribution, click on the “Make Your Mark” button at the top of this page. For more information on funding a specific project, please contact Ken Koskela at ken.koskela@rowpharma.org.

One World. One Standard.

Completed Projects
Ongoing Projects
Future Projects
Multiple Projects

Diagnosis and Treatment Grants (Multiple)

In 2015 a diagnosis grant in the form of a 32-channel video EEG workstation was given to the Armenia League Against Epilepsy, to be placed at Arabkir Pediatric Hospital in the capital city of Yerevan. Beginning in October 2016, an ongoing treatment grant has been supplying the hospital with Roweepra® (levetiracetam USP) anti-seizure medication. This is an ongoing commitment of medication, to be resupplied every six months.

Treatment Grant (Ongoing)

In 2018, a treatment grant of Roweepra® (levetiracetam USP) was provided to Solidarity Bridge/Puente Solidaridad for use in the nation’s first comprehensive epilepsy center at Belga Hospital in Cochabamba, Bolivia. This is an ongoing commitment of medication, to be resupplied as needed.

Diagnosis Grant (Future)

The ROW Foundation is hoping to grant mobile EEG equipment to assist with the diagnosis and monitoring of epilepsy patients in outlying, under-resourced areas of Cameroon. When the grant is fully implemented, EEG scans will be able to be transmitted via the internet and read by volunteer neurologists in the United States, who can then provide diagnoses to health care providers in Cameroon.

Training Grant (Future)

The ROW Foundation hopes to partially fund a new neuro-diagnostic training program at a university in northern Cameroon.

Training Grant (Completed)

In 2017, a training grant was provided to the Global Organization of Health Education (GOHE) for the purchase of technical materials to be used in training EEG technicians at Mekelle University in Ethiopia.

Diagnosis Grant (Future)

The ROW Foundation is hoping to grant a 32-channel video EEG workstation to an epilepsy society headquartered in Accra, Ghana for use in diagnosing and monitoring epilepsy among under-resourced populations in the greater Accra area. The epilepsy society will make the equipment available through various clinics and coordinate its use.

Diagnosis Grant (Future)

The ROW Foundation is hoping to grant a 64-channel video EEG workstation to a neurology center in Guatemala City, Guatemala to assist with diagnosing and monitoring patients with epilepsy due to traumatic brain injury, and patients with forms of epilepsy resistant to typical forms of treatment.

Treatment Grant (Ongoing)

In 2017, a treatment grant was provided to Children’s Hope, a US-based nonprofit operating a medical/dental clinic in Jacmel. This grant provides Roweepra® (levetiracetam USP) for epilepsy patients being treated through the clinic. This is an ongoing commitment of medication, to be resupplied as needed.

Treatment Grant (Ongoing)

In 2018 a treatment grant of Roweepra® (levetiracetam USP) anti-seizure medication was provided to the CLIDEP Epilepsy Clinics in Haiti to augment medications available locally for treating patients with epilepsy. Initially the medication will be used for the CLIDEP clinics in Port-au-Prince and Jacmel, with possible expansion to the clinic in Mirebalais as well. This is an ongoing commitment of medication, to be resupplied every six months as needed.

Treatment Grant (Ongoing)

In 2018, a treatment grant was provided to Concerned Haitian Americans of Illinois (CHAI), a US-based nonprofit operating a medical clinic in a rural area near Cap-Haitien. This grant provides Roweepra® (levetiracetam USP) for epilepsy patients being treated through the clinic and students from CHAI’s two schools. This is an ongoing commitment of medication, to be resupplied as needed.

Diagnosis Grant (Future)

The ROW Foundation is hoping to grant mobile EEG equipment to two rural hospitals in India. When the grants are fully implemented, EEG scans will be able to be transmitted via the internet and read by volunteer neurologists in the United States, who can then provide diagnoses to health care providers at the hospitals in India.

Diagnosis Grant (Completed)

In 2018, the ROW Foundation granted funds to Santokba Durlabhji Memorial Hospital for the purchase of a portable 32-channel video EEG workstation in Jaipur, India. This EEG will be used in the pediatric ICU for diagnosis and monitoring of epilepsy for children in the greater Jaipur area.

Treatment Grant (Ongoing)

In 2018, the ROW Foundation provided a treatment grant of Roweepra® (levetiracetam USP) anti-seizure medication to the Kenya Association for the Welfare of People with Epilepsy. This is an ongoing commitment of medication, to be resupplied every six months.

Diagnosis Grant (Completed)

In 2016, mobile EEG equipment was provided to AIC Kijabe Hospital, a rural hospital in the Great Rift Valley of Kenya that had no EEG equipment, and no resident neurologists to read EEG studies. Through a grant to the Christian Medical and Dental Associations (CMDA), the equipment was placed, hospital staff were trained, and a mechanism for transmitting the EEG studies to volunteer neurologists in the United States was established. This allows volunteer neurologists to make diagnoses based on the EEG study data and to communicate with the health care providers at the hospital in Kenya who then provide treatment. Leveraged partnerships also resulted in a duplicate project at Tenwek Hospital.

Diagnosis Grant (Future)

The ROW Foundation hopes to fund an epilepsy support organization to expand their ongoing telehealth program in western Nepal.

Diagnosis Grant (Future)

The ROW Foundation is hoping to grant a 32-channel video EEG workstation to a hospital in Abakaliki, Nigeria for use in diagnosing and monitoring epilepsy among under-resourced populations in the greater Abakaliki area.

Training Grant (Future)

The ROW Foundation hopes to partially fund the launch of a new professional organization for neuro-diagnostic technicians in Africa.

Diagnosis Grant (Completed)

In 2018, a diagnosis grant in the form of a 32-channel video EEG workstation was given to the Georgian League Against Epilepsy, to be placed at the Institute for Neurology and Neuropsychology in Tbilisi. The new EEG workstation will allow the institute to diagnose under-resourced individuals with hard-to-treat epilepsies.

Treatment Grant (Ongoing)

In 2018, the ROW Foundation started providing anti-seizure medication to Loreto Clinic in the city of Makeni. Roweepra® (levetiracetam USP) anti-seizure medication augments locally available medication for treating patients with epilepsy. This is an ongoing commitment with the possibility of expanding to three additional sites.

Treatment Grant (Ongoing)

In 2018, the ROW Foundation provided Roweepra® (levetiracetam USP) for Medical Assistance Sierra Leone (MASL), a UK-based organization. In 2010, MASL and local partners established the first clinical epilepsy service in Sierra Leone. The supply is dispensed by Epilepsy Association Sierra Leone and will be replenished as needed.

Shipment of this grant was made possible by the Healey International Relief Foundation. 

Diagnosis Grant (Future)

The ROW Foundation is hoping to grant a 32-channel video EEG workstation to an epilepsy society in Mbabane, Swaziland for use in diagnosing and monitoring epilepsy patients in outlying, under-resourced areas.

Treatment Grant (Completed)

In 2017, a grant was provided to the Guiding Light Orphans (GLO) organization in Uganda to assist with the purchase of locally-available anti-seizure medications, and to support operation of their mobile epilepsy clinics.

Treatment Grant (Ongoing)

In 2017, a treatment grant was provided to CURE Children’s Hospital of Uganda, located in Mbale. This grant provides Roweepra® (levetiracetam USP) to augment the medications available for treating patients with epilepsy. This is an ongoing commitment of medication, to be resupplied every six months.

Treatment Grant (Completed)

In 2016, a grant was provided to Epilepsy Health Management (EHM) to assist with modifications to a local epilepsy clinic in northern Illinois that will allow epilepsy patients with mobility issues – often as a result of traumatic brain injury – to access services more easily.

Treatment Grant (Ongoing)

In 2017, treatment grants were made to two Epilepsy Foundation chapters in the United States: one to the Epilepsy Foundation of North Carolina, and the other to the Epilepsy Foundation of North/Central Illinois. The grants consisted of Roweepra® (levetiracetam USP) and are being used to provide care for epilepsy patients temporarily unable to access care independently.

Treatment Grant (Completed)

In October 2017 ROW partnered with the Epilepsy Foundation of Greater Chicago and Dr. Rebecca Garcia Sosa of Lurie Children’s Hospital in Chicago to deliver a medication humanitarian aid shipment to Hospital Pediátrico Universitario (HOPU) in San Juan, Puerto Rico in the aftermath of Hurricane Maria. Dr. Janice Rodriguez Hernandez, Child Neurology Chief Resident, Fundación Hospital Pediátrico, was responsible for coordinating the distribution of the medication to where it was most needed until commercial pharmaceutical distribution could be restored. This was ROW’s largest single grant to-date, representing about $35,000 worth of medication.

Treatment Grant (Completed)

In 2018, the ROW Foundation granted 125 cases of Roweepra® (levetiracetam USP) to Cuatro por Venezuela, a Houston-based relief organization. This humanitarian aid shipment, delivered to the Venezuelan League Against Epilepsy (LIVECE), gives 1,000 patients access to anti-seizure medication and provides relief from severe drug shortages.

Training Grant (Future)

The ROW Foundation hopes to partially fund neuro-diagnostic technician training at an epilepsy association in Harare.

Make Your Mark!